Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients.

doi:10.18632/oncotarget.11143

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients.

Oncotarget - 13 Sept 2016

Yuan Xiao-Qing, Zhang Dao-Yu, Yan Han, Yang Yong-Long, Zhu Ke-Wei, Chen Yan-Hong, Li Xi, Yin Ji-Ye, Li Xiao-Lin, Zeng Hui, Chen Xiao-Ping

Abstract excerpt

DNMT3A mutation is known as a recurrent event in acute myelogenous leukemia (AML) patients. However, association between DNMT3A genetic polymorphisms and AML patients' outcomes is unknown. DNMT3A 11 SNPs (rs11695471, rs2289195, rs734693, rs2276598, rs1465825, rs7590760, , , , and ) were genotyped in 344 diagnostic non-FAB-M3 AML patients from southern China. Patients...

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to China
Share to DNA (Cytosine-5-)-Methyltransferases
Share to DNA Methyltransferase 3A
Share to Genetic Association Studies
Share to Leukemia, Myeloid, Acute
Share to Survival Analysis
Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 27528035
DOI: 10.18632/oncotarget.11143
PMCID: PMC5312402

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients.PMID 27528035Read ↗

DNMT3A mutation is a poor prognosis biomarker in AML: results of a meta-analysis of 4500 AML patients.Semantic proximity Read ↗

Association between DNA methyltransferases 3B gene polymorphisms and the susceptibility to acute myeloid leukemia in Chinese Han population.Semantic proximity Read ↗

DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemiaSemantic proximity Read ↗

Prognostic significance of DNMT3A mutations in patients with acute myeloid leukemia.Semantic proximity Read ↗

[Effects of DNMT3A gene mutations on prognosis of patients with acute myeloid leukemia: a meta-analysis].Semantic proximity Read ↗

Acute myeloid leukemia with DNMT3A mutations.Semantic proximity Read ↗

Association between DNMT3A mutations and prognosis of adults with de novo acute myeloid leukemia: a systematic review and meta-analysis.Semantic proximity Read ↗

Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.Semantic proximity Read ↗

Biologico-clinical significance of DNMT3A variants expression in acute myeloid leukemia.Semantic proximity Read ↗

Significance of targeting DNMT3A mutations in AML.Semantic proximity Read ↗

[DNMT3A gene mutations in acute myeloid leukemia].Semantic proximity Read ↗

Characteristics of DNMT3A mutations in acute myeloid leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.